NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cataya Bio

Cataya Bio

Private
ShanghaiHealthcare & Life Scienceshttps://cataya.com/

Last Round

Series B

Sep 4, 2023

Total Funding Raised

$64.3M

Company Overview

Cataya Bio is a biotechnology company that develops and delivers high-performance, value-added ingredients and solutions using a world-class engineering biology platform and fermentation facilities.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Infrastructure

Keywords

synthetic biologysynbiobiomanufacturingprecision fermentationbio-based ingredientsbiofoundrypersonal care ingredientsstrain engineeringbiotech CDMOsustainable ingredientsHuman Milk OligosaccharidesHMOsclean beauty ingredientsfood ingredientsDesign-Build-Test-LearnDBTLSqualaneCeramidesAI-driven biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cataya Bio Comparables

Compare Cataya Bio with similar companies based on industry and business-model similarity.

Cataya Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hangzhou Viablife Biotech Co., Ltd.
84%
Conagen
83%
MicroCyto Biotechnology (Beijing) Co., Ltd.
79%

Cataya Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 4, 2023
Series A ExtensionNov 4, 2022
Series AMay 19, 2022

Key People

Founding team and executive leadership

Lishan Zhao

CEO & Founder

Founding Team

Hanxiao Jiang

Chief Technology Officer

Executive Team

Cataya Bio Investors

Notable investors and investment history

Cataya Bio investors
InvestorRounds
Bits x BitesSeries A, Series A Extension, Series B
Eight Roads VenturesSeries A Extension, Series B
Hengxu CapitalSeries B
F-Prime CapitalSeries A Extension
Source Code CapitalSeries A Extension, Series A
Sherpa Healthcare PartnersSeries A
HongShan Capital Group (HSG)Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors grew 150% MoM, reaching 1.2K.

  • Sep 4, 2023

    $34M round led by Hengxu Capital and Eight Roads Ventures

Cataya Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cataya Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cataya Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range7
Year Founded2021
Last FundingSep 4, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.